Zealand Pharma A/S (ZLDPF)

41.99 -1.12 (-2.59%) USD  |  OTCM  |  Sep 24, 16:00
More

Zealand Pharma Cash and Short Term Investments (Quarterly) : 2.211B for June 30, 2026

Cash and Short Term Investments (Quarterly) Chart

View Cash and Short Term Investments (Quarterly) for ZLDPF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash and Short Term Investments (Quarterly) Chart
Start Trial

Historical Cash and Short Term Investments (Quarterly) Data

View and export this data back to 2011. Start Trial.
Date Value
June 30, 2026 2.211B
March 31, 2026 2.231B
December 31, 2025 2.376B
September 30, 2025 2.545B
June 30, 2025 2.608B
March 31, 2025 1.237B
December 31, 2024 1.142B
September 30, 2024 1.268B
June 30, 2024 1.284B
March 31, 2024 468.37M
December 31, 2023 241.99M
September 30, 2023 224.64M
June 30, 2023 247.97M
March 31, 2023 146.07M
December 31, 2022 169.04M
September 30, 2022 96.17M
June 30, 2022 121.52M
March 31, 2022 189.27M
December 31, 2021 218.36M
September 30, 2021 163.49M
June 30, 2021 204.60M
March 31, 2021 253.50M
December 31, 2020 206.72M
September 30, 2020 240.81M
June 30, 2020 247.89M
Date Value
March 31, 2020 189.78M
December 31, 2019 207.38M
September 30, 2019 225.34M
June 30, 2019 174.26M
March 31, 2019 190.01M
December 31, 2018 177.58M
September 30, 2018 230.30M
June 30, 2018 72.29M
March 31, 2018 92.58M
December 31, 2017 107.06M
September 30, 2017 124.01M
June 30, 2017 47.29M
March 31, 2017 59.97M
December 31, 2016 47.80M
September 30, 2016 35.85M
June 30, 2016 45.88M
March 31, 2016 51.54M
December 31, 2015 64.08M
September 30, 2015 67.91M
June 30, 2015 69.99M
March 31, 2015 75.33M
December 31, 2014 87.47M
September 30, 2014 51.56M
June 30, 2014 54.66M
March 31, 2014 64.55M

Cash and Short Term Investments Definition

Represents the sum of cash and short term investments.

Read full definition.

Cash and Short Term Investments (Quarterly) Range, Past 5 Years

View Cash and Short Term Investments (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash and Short Term Investments (Quarterly) Benchmarks

View Cash and Short Term Investments (Quarterly) Benchmarks
Start Trial
Genmab A/S 1.503B
Ascendis Pharma A/S 928.66M
Bavarian Nordic A/S 360.60M
Evaxion AS 14.00M
ACADIA Pharmaceuticals, Inc. 956.47M